Member Info for subush79

Stu

You have changed your stances from HEMO failing to now going to have successful product with efficacy.

I can guarantee you are a trader and trying to manipulate market for your personal greed. Your posts are not to inform investors. You are a cunning man. I have invested for science and I know science is working. P1 is on almost in 6 months without negative information and P2 is 3+ months.

Grants for clean rooms- speed up work and potential income generation to HEMO. All looking good for me as a genuine investor.

We are in the verge of getting very positive news soon. May be in a week, a mont or few months. 6 month is 24th August anyway. AIMO

Hey Stu,

I guess you need some mental health support. Please consult your doctor as it is not too late I guess. I have been reading your post for few days and nothing makes any sense. Enjoy your life and try to live good life.

Stu

Why we need to research what you saying? Are you invested person or trying to creat fear to potential PI?

I have invested and confident on science. 1st patient still doing good for 5th month is very assuring. Getting paediatric trial authorisation from FDA is remarkable for HEMO.

I am a investor and keep holding my shares. It seems that you are paid by someone to defame HEMO. Just my instinct started to feel that way.

You haven’t answered if you are invested as many have asked you this before. If you answer this then I will probably change my mind about your intention.

Good luck everyone and Happy Friday.

Previous Placee selling at loss as they know next placing is coming @150p or less IMO

Share price is down not because of product. It is because of demand and supply. There are still big chunk to sell by subscriber I guess.

However, the product Hemo is trialing on patient is working well for 2 patients and 3rd patient is on the process of treatment.

Hemo has progressed in this level with meagre resources and hope LTH will be rewarded soon once Hemo get partnered with big Pharma. It is best time to buy this share in my opinion. There might be some dilution to progress further until Hemo get good deal with big Pharma. AIMO.

DYOR everyone whoever want to involve in this share. Do not listen to anyone either positive or negative comments from other people. Look company information and RNS as those are the relevant information.

Stu

What is your agenda here? I read your post and it doesn’t make any sense to me in terms of the products Hemo is on trial with MD Anderson. If it was not safe product then how come they can request for Paediatric trial? It is very simple common sense and you trying to create negativity. In terms of disclosing efficacy I hope they will do when time comes. Just invest or stay away from this board.

Some announce. Others discuss. At Hemogenyx Pharmaceuticals, we execute.

As the #SBA launches its Made in America Manufacturing Initiative to strengthen domestic biomanufacturing, Hemogenyx Pharmaceuticals (LSE: HEMO) has already delivered.

Our in-house, U.S.-based GMP facility is fully operational and currently producing HG-CT-1, our next-generation CAR-T therapy for relapsed/refractory AML. Manufacturing for our second clinical trial patient is about to be finished—a clear signal of scientific and operational maturity.

While policy and funding frameworks are catching up to the needs of biotech innovation, Hemogenyx is ahead of the curve—de-risking critical manufacturing capabilities and demonstrating real-world progress in a space where execution is everything.

We welcome the SBA’s initiative and the visibility it brings to advanced therapies made in the U.S. For our investors and partners, it reaffirms the importance of what we’ve already built—and the unique opportunity it represents.

#Hemogenyx #BiotechInvesting #CellTherapy #GMP #MadeInAmerica #CAR_T #AML #ClinicalTrials #Biomanufacturing #DeepTech

Very reassuring about the work HEMO is doing.

There are 4.09m shares issue. Current mcap is correct

What about Vlad? Don’t you think Vlad should be fired as a CEO and given different responsibility as a scientist? This guy is not capable for management at all.

Most of us are on the same boat and have same issue with mental health. However, money can be earned if we keep our health strong. I have £7200 left from my £32k investment. Vlad and team will get return for their Karma. Look how many people angry here and that negative vibes definitely punish Vlad for his Karma.

Does anyone has any valid and genuine information about 20% share issue in 12 months for main market company? Hemo has already issued 489k excluding warrants. Their 20% of 3.6m shares is 720k. Thanks

LTH

Don’t think about profit anymore. Just think how much loss you can take and exit from this share. I am happy to exit if this reaches 1p old money. I am planning to loose 50% of my investment. Let’s see.

Those ii are selling shares now as otherwise how come this much share available to buy in this low price. Let’s see they will finish their share very soon as buying pressure is huge now.

It is not negative Mr I as that is what you wrote. Which placee is selling on that price otherwise?

First one i guess already sold their subscription (100000 shares) and has not exercised warrants yet, which is 500p.

I am not against on selling shares as that is their choice but only thing I am concerned is when they pretend something different. Company will be in strong position once the result is out, which I am confident that is very positive.

Pumpky, MrI has been selling shares on that price as he was one of the subscribers at 300p and warrants at 400p. I know, he has not got subscribed shares yet but selling old shares gives access to money for next placing. He is expecting to get next subscription as well. Otherwise how come he confidently say that price will not rise until that clear on specific price? My assumption.

Ask is down now. I love these sellers getting less than 300p as there is no more price increases until these sellers are cleared. I am holding until 4th patients trial and step in of big pharma.

In my opinion there is no issue with trial as if there was an issue then Vlad should have updated market immediately. However, company need more money by end of this month I guess and in next 2 weeks company get clear picture of 1st patients situation interms of trial. Hope that will help to involve to big pharma for further trial process.

I guess some of the CLN subscribers already sold from their old holdings and waiting for shares to issue. They are looking for next placings and subscribe again. Next placing should be higher that last 2 placings I guess.

If takeover is for £200 then I go with Yes vote.

30th January